Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Hemorrhage 13Neoplasms 7Leiomyoma 7Breast Neoplasms 6Postoperative Hemorrhage 4Hematologic Neoplasms 4Thrombocytopenia 3Myofibroma 3Meningioma 3Blood Loss, Surgical 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Seroma 2Seizures 2Prostatic Neoplasms 2Postoperative Complications 2Ovarian Neoplasms 2Menorrhagia 2Head and Neck Neoplasms 2Colonic Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2Wrist Fractures 1Urologic Diseases 1Urinary Tract Infections 1Urinary Retention 1Thromboembolism 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1

Interventions

Doxorubicin 142Ifosfamide 85Radiotherapy 82Cyclophosphamide 72Gemcitabine 63Filgrastim 54pembrolizumab 43pazopanib 40Etoposide 39Docetaxel 39Vincristine 37Trabectedin 37Cisplatin 35Nivolumab 32Magnetic Resonance Spectroscopy 26Irinotecan 26Carboplatin 25Temozolomide 23Surgical Procedures, Operative 23Radiation 22Ipilimumab 22Bevacizumab 20Blood Specimen Collection 19Granulocyte Colony-Stimulating Factor 18Biopsy 18eribulin 17Sirolimus 17Mesna 17Melphalan 17Dactinomycin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Tranexamic Acid × Clear all
NCT04347122 2025-05-21

Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction

University of Kansas Medical Center

Phase 4 Terminated
12 enrolled 6 charts
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡